Prosthetic Valve Endocarditis: Epidemiology, Clinical Manifestations, and Diagnosis
UptoDate June 2018, Karchmer, A.W. & Chu, V.H., 2018
Infective Endocarditis at Autopsy
Medicine 91:152-164, Fernandez Guerrero,M.L.,et al, 2012
Complications and Outcome of Infective Endocarditis
UpToDate January, Spelman, D. & Sexton, D., 2012
Bicuspid Aortic Valve - A Silent Danger: Analysis of 50 Cases of Infective Endocarditis
Clin Inf Dis 30:336-341, Lamas, C.C. & Eykyn, S.J., 2000
Relationship of Cardiac Disease to Stroke Occurrence, Recurrence, and Mortality
Stroke 23:1250-1256, Broderick,J.P.,et al, 1992
Cerebrovascular Disorders of Infancy
In Handbk of Clin Neurol, Elsevier Sci Publ, NY, 2:3188., Salam-Adams,M.&Adams,R.D., 1988
The Significance of Nonbacterial Thrombotic Endocarditis:An Autopsy & Clinical Study of 78 Cases
Ann Int Med 46:255, MacDonald,R.A.,et al, 1957
A Brewing Back Pain
NEJM 385:66-72, Pischel, L.,et al, 2021
Cerebrovascular Accidents During Mechanical Circulatory Support
Stroke 49:1197-1203, Izzy, S.,et al, 2018
Chronic Heart Failure and Ischemic Stroke
Stroke 42:2977-2982, Haeusler, K.G.,et al, 2011
Recurrent Ischemic Events in Young Adults After First-Ever Ischemic Stroke
Ann Neurol 68:661-671, Putaala,J.,et al, 2010
Left Ventricular Systolic Dysfunction and the Risk of Ischemic Stroke in a Multiethnic Population
Stroke 37:1715-1719,1637, Hays,A.G.,et al, 2006
The Management of Vein of Galen Aneurysmal Malformations
Neurosurgery 59:S3 184-194, Lasjaunias,P.L.,et al, 2006
Cabergoline-Related Severe Restrictive Mitral Regurgitation
NEJM 353:1974-1975, Rosen,C.J., 2005
Risk Factors for Obstructive Sleep Apnea in Adults
JAMA 291:2013-2016, Young,T.,et al, 2004
Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy
Stroke 34:901-908, Boriani,G.,et al, 2003
Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003
Stroke in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction
Neurol 54:288-294, Pullicini,P.M.,et al, 2000
Stroke Associated with Cardiac Surgery, Determinants, Timing, & Stroke Subtypes
Arch Neurol 54:83-87, Libman,R.B.,et al, 1997
Complications of Intravenous Immune Globulin Treatment in Neurologic Disease
Neurol 47:674-677, Brannagan III,T.H.,et al, 1996
Treatment of End Stage Dilated Cardiomyopathy
Br Heart J 72:S52-S56, O'Connell,J.B.,et al, 1996
Predictors of Thromboembolism in Atrial Fibrillation:I. Clinical Features of patients at Risk
The Stroke Prevention in A Fib Investigators, Ann Int Med 116:1-51992., , 1992
Irregular Breathing
In Internal Medicine, Little, Brown & Co, Boston, 3rd Ed, p. 573-574, Cherniack,N.S., 1990
Stroke in the Lehigh Valley:Combined Risk Factors for Recurrent Ischemic Stroke
Neurol 39:669-672, Sobel,E.,et al, 1989
Stroke Rehabilitation Outcome:Impact of Coronary Artery Disease
Stroke 19:42-47, Roth,E.J.,et al, 1988
Cardiac Involvement in Myotonic Muscular Dystrophy
Medicine 64:371-387, Moorman,J.R.,et al, 1985
Computed Tomographic Changes of Hypertensive Encephalopathy
AJNR 6:395-398, Weingarten,K.L.,et al, 1985
Clinicopathological Conference
Case 2-1984, Fabry's Disease, NEJM 310:106-114984., , 1984
Manifestations of Coronary Disease Predisposing to Stroke
JAMA 250:2942-2946, Kannel,W.B.,et al, 1983
Cerebral Embolism as the Initial Manifestation of Peripartum Cardiomyopathy
Neurol 32:668-671, Hodgman,M.T.,et al, 1982
Superior Sagittal Sinus Thrombosis
Arch Neurol 34:2, Gettelfinger,D.M.,et al, 1977
Eosinophilic Polymyositis
Ann Neurol 1:65, Layzer,R.B.,et al, 1977
Nonbacterial Thrombotic Endocarditis
Arch Int Med 125:126, Wooley,C.F.,et al, 1970
Clinicopathologic Conference, Systemic Immunoglobulin Light-Chain (AL) Amyloidosis
NEJM 389:166-175, Case 21-2023, 2023
Pernicious Anaemia
BMJ 369:m1319, Mohamed, M.,et al, 2020
Clinicopathologic Conference, Cushings syndrome due to a well-differentiated, low-grade thymic neuroendocrine tumor with corticotropin
NEJM 378:2322-2332, Case 18-2018, 2018
Cardiovascular Dysfunction in Multiple Sclerosis
Neurologist 20:108-114, Kaplan, T.B.,et al, 2015
Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Diptheria
Adams & Victors Principles of Neurology Chp 43, pg 1217, Ropper, A.H.,et al, 2014
Degenerative Diseases of the Nervous System, Friedreich Ataxia
Adams & Victors Principles of Neurology, Chp 39, pg 1102, Ropper, A.H.,et al, 2014
Tumor Necrosis Factor-Alpha Inhibitors: An Overview of Adverse Effects
UpToDate January, Stone, J.H., 2013
Clinical Reasoning: A 12-year-old Boy with Ascending Weakness
Neurol 80:e110-ee114, French, K.F.,et al, 2013
Cardiac abnormalities in a follow-up study on carriers of Duchenne and Becker muscular dystrophy
Neurol 77:62-66, Schade van Westrum, S.M.,et al, 2011
LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011
Evidence Report: The Efficacy and Safety of Mitoxantrone (Novantrone) in the Treatment of Multiple Sclerosis: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurol 74:1463-1470, Marriott,J.J., et al, 2010
Aldosterone-Producing Adrenal Adenoma and Idiopathic Intracranial Hypertension- A Pathogenetic Link for Aldosterone?
Q J Med 103:699-702, Chitalia, N.,et al, 2010
Severe Cardiac Failure in a Patient with Multiple Sclerosis Following Low-Dose Mitoxantrone Treatment
Neurol 73:991-993, D�rr,J.,et al, 2009
Autoimmune Targets of Heart and Skeletal Muscles in Myasthenia Gravis
Arch Neurol 66:1334-1338, 1322, Suzuki,S.,et al, 2009
Cardiac Encephalopathy and Congestive Heart Failure
Neurol 66:99-101, Caplan,L.R., 2006
Glycogen-Storage Disease Type II
eMedicine, May 2, Ibrahim,J. &McGovern,M., 2006